ANTIOBESITY AGENT FOR PRADER-WILLI SYNDROME

摘要

The invention further PRA - relates to an appetite suppressant for Willy syndrome. In particular the invention PRA more insulin which can prevent the complications caused by the typically obesity and obesity caused by at Willy syndrome Willie by decreasing the blood ghrelin levels in patients with specific to suppress appetite, PRA more comprises as an active ingredient, more plastic having a dosage of 30 to 50 mIU - it provides an appetite suppressant for Willy syndrome. ; The PRA-Willy syndrome, ghrelin, insulin,